Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.
General
| Name | Jazz Pharmaceuticals plc |
| Ticker | JAZZ |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 2,800 |
Highlights
| Analyst Target | 186.12 |
| Market Cap | 6,816,300,000 |
| PE Ratio | 15.19 |
| PEG Ratio | 4.46 |
| EBITDA | 1,392,039,040 |
Share Stats
| Shares Outstanding | 61,620,000 |
| Shares Float | 57,780,000 |
| Shares Short | 5,870,000 |
| Insider Holdings | 307% |
| Institution Holdings | 101.94% |
Highlights
| Analyst Target | 186.12 |
| Market Cap | 6,816,300,000 |
| PE Ratio | 15.19 |
| PEG Ratio | 4.46 |
| EBITDA | 1,392,039,040 |
Valuation
| Trailing PE | 15.34 |
| Forward PE | 13.81 |
| Price/Sales (Trailing 12 Mt.) | 1.68 |
| Price/Book (Most Recent Quarter) | 1.64 |
Earnings
Jim Cramer Made 'FAANG' Popular, Now He Says There's A New Acronym To Describe These Retail Favorite Stocks — 'PARC'
Renowned TV host Jim Cramer is stirring chatter on X with another buzzworthy "meme stock" acronym, aimed at a new group of retail-favorite stocks that are defying gravity.
Colonel Sanders Sold KFC For $2 Million Only To See The New Owners Cash Out For $285 Million Few Years Later — Why He Then Sued Them
Harland Sanders built Kentucky Fried Chicken into a success but sold it for just $2M, feeling sidelined as it grew into a global brand. He died in 1980.
Have You Seen this Strange Elon Musk Device? - Ad
Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.
What to know about buying electric vehicles after the federal tax incentives end
The massive tax and spending cut bill that ends federal tax incentives for electric vehicles.
Trump's Megabill Brings Tax Breaks for the Wealthy and Welfare Cuts — Here's How Your Income Taxes Could Change
President Trump signed his massive spending and social policy bill into law during an Independence Day event at the White House on Friday.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Tesla Cybertruck Bet Not Paying Off? Ford, GM Outsell EV Giant
Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see declining demand.
Trump's 'Happy Crypto Week' Gets Off To Rocky Start As House Suspends Votes On Key Bills
The House of Representatives called off Tuesday’s votes on pivotal cryptocurrency bills, citing a procedural failure.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Carney Faces Cross-Border Pressure Amid High-Stakes US Trade Talks
Carney faces growing criticism at home as Trump threatens steep tariffs amid tense Canada-U.S. trade negotiations.
Dave Ramsey Values A Quality Marriage And Relationship Over Money, He Once Schooled A Caller Who Hid Money From Wife That 'Spends Too Much'
Dave Ramsey stresses the importance of honesty in marriage over financial wealth, calling out a caller for hiding money from his wife due to cultural differences.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Retirees, here’s how to tweak the 4% rule to protect your nest egg
New retirees might enter a different environment than their predecessors—the economy or market might have changed slightly or dramatically.
Cathie Wood Doubles Down On Tesla Despite Leadership Exodus, Dumps $22 Million Of Crypto Stocks Amid Bitcoin Buzz
Cathie Wood-led Ark Invest made significant trades on Tuesday, involving major companies like Tesla Inc. (NASDAQ:TSLA), Coinbase Global Inc.
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.
Inside the high-stakes battle to win a New York City casino license
NEW YORK (AP) — A Caesars Palace casino in the heart of Times Square. A sprawling gambling hall along Coney Island’s iconic boardwalk. A Hard Rock casino complex next to the home stadium of baseball’s New York Mets.
ASML Stock Plunges Nearly 8% In Wednesday Pre-Market: What's Going On?
Shares of Dutch semiconductor firm, ASML Holding NV (NASDAQ: ASML), has declined 7.46% during Wednesday pre-market trading, after the company expressed concerns over its 2026 growth prospects.
Only Days Left to Claim Your Share of Trump's $100T Play - Ad
Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.
What's Fueling ON Semiconductor's Recent Stock Surge?
ON Semiconductor has recently seen a significant surge, gaining over 47% in the last three months and outperforming the index's 34% rise, and it currently trades above its 50-day moving average of $47.56.
Whistleblower's Texts Allege Ex-Trump Lawyer Bove Encouraged Lawbreaking. Now He's Up for a Judgeship.
Emil Bove is on the verge of a lifetime appointment as a judge, despite allegations of professional misconduct.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
Tesla Rival Xiaomi Wants To Sell Cars Internationally Starting 2027, CEO Lei Jun Says
Xiaomi plans to sell its electric vehicles overseas as SU7 and YU7 models gather steam in the Chinese domestic market.
Nvidia-Supplier Taiwan Semiconductor On A Roll, Profit Explodes With Strong Margin Growth
Taiwan Semiconductor (TSM) reports strong Q2 results and expects continued growth in demand for advanced processor technologies, with revenue guidance of $31.8 billion to $33.0 billion for Q3.
Crypto Genius: These 5 Altcoins Could Crush Bitcoin in 2025 - Ad
On August 30th, two powerful "Wealth Drivers" ignite what could be a 2025 super bull run-backed by Trump. The altcoin market as a whole has already soared 132,721% over the past ten years and could surge again. A $900 stake could turn into $108K over 12 months. This is The Great Gain of 2025.
MP Materials, Nvidia, AMD, Alibaba And Tesla: Why These 5 Stocks Are On Investors' Radars Today
Major indices were mixed on Tuesday with the Dow Jones Industrial Average falling nearly 1% to 44,023.29.
Nvidia Is 'On A March To $5 Trillion' Market Capitalization, Says Dan Ives As He Predicts Bullish Environment For Tech And Crypto: 'Very Strong Second Half'
Wedbush analyst Daniel Ives delivered an optimistic outlook for Nvidia Corp. (NASDAQ:NVDA) and the broader tech and crypto markets, predicting a $5 trillion market capitalization for the tech giant led by Jensen Huang.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Capgemini Doubles Down On Agentic AI With $3.3 Billion WNS Acquisition
Capgemini acquires WNS for $3.3B, creating a global leader in AI-powered Intelligent Operations. Deal expected to close by year-end.
Indigenous Wampis are ambushed in Peru after government backs out of anti-mining joint patrol
BOGOTA, Colombia (AP) — An attack by armed assailants on a patrol of a mission by the guards last week in the Peruvian Amazon has again brought into focus the issue of .
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
Is Costco Stock Topping Out? Key Price Levels To Watch
Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.
Have You Seen this Strange Elon Musk Device? - Ad
Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.
Mattel introduces its first Barbie with Type 1 diabetes
NEW YORK (AP) — Mattel has introduced its first Barbie representing a person with Type 1 diabetes, as part of wider efforts from the toy maker to increase inclusivity among its dolls.
ASML Rises 1.1% After Key Trading Signal
A significant trading signal occurred for ASML Holding stock as it demonstrated a power inflow at $817.45, after which ASML rose up to 1.1%.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
ProKidney Stock Shoots Up Over 8% After Hours After Staggering 515% Rally On Wednesday
ProKidney (NASDAQ: PROK) experienced a surge of 515% during Tuesday's trading session and gained additional 8.58% after-hours to $4.05 on positive Phase 2 trial results, with trading volume seeing a jump to 39.8 million shares from an average of 1.12 million.
Trump appointees pushed more marble in Fed building renovation White House now attacks
WASHINGTON (AP) — President Donald Trump has looked to the marble finishes and hefty price tag of the Federal Reserve headquarters to to fire Chair Jerome Powell, with whom he has tussled for years over interest rates. But the extensive use of marble in the building is, at least in part, the result of policies backed by Trump himself.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Tesla debuts in India with upscale showroom launch in Mumbai
NEW DELHI (AP) — opened its first showroom in on Tuesday, marking the electric vehicle maker’s long-anticipated debut in the world’s third-biggest automotive market.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.